Oversea Chinese Banking Corp LTD Gilead Sciences, Inc. Transaction History

Oversea Chinese Banking Corp LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$63.15 - $72.88 $530,270 - $611,973	8,397 Added 241.09%	11,880 $815,000
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $249,313 - $304,031	3,483 New	3,483 $255,000
Q3 2023 Apr 29, 2024	BUY	$73.94 - $80.67 $1.17 Million - $1.28 Million	15,862 New	15,862 $1.19 Million
Q3 2023 Nov 03, 2023	BUY	$73.94 - $80.67 $1.17 Million - $1.28 Million	15,862 New	15,862 $1.19 Million
Q1 2023 Sep 15, 2023	BUY	$77.31 - $88.08 $533,980 - $608,368	6,907 Added 214.64%	10,125 $840,000
Q4 2022 Sep 15, 2023	BUY	$62.32 - $89.47 $200,545 - $287,914	3,218 New	3,218 $276,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $200,545 - $287,914	3,218 New	3,218 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.